Human Epidermal Growth Factor Receptor-2 Gastric Adenocarcinoma: Expanding Therapy of a Recognized Target

SIMPLE SUMMARY: Human epidermal growth factor receptor-2 (HER2) is a well-known target for approximately 15% of gastric adenocarcinomas (GACs). Although a plethora of HER2-targeted agents are marketed, currently only two agents are approved for GAC. These two agents are used only in the metastatic s...

Descripción completa

Detalles Bibliográficos
Autores principales: Rogers, Jane E., Yamashita, Kohei, Sewastjanow-Silva, Matheus, Trail, Allison, Waters, Rebecca E., Ajani, Jaffer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10650285/
https://www.ncbi.nlm.nih.gov/pubmed/37958354
http://dx.doi.org/10.3390/cancers15215180

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10650285/
https://www.ncbi.nlm.nih.gov/pubmed/37958354
http://dx.doi.org/10.3390/cancers15215180

Ejemplares similares